Is My IUD Causing Bacterial Vaginosis?

Copper IUDs carry a real and measurable link to bacterial vaginosis. A large prospective study found that copper IUD users faced about 28% higher BV risk compared to women using no contraception or other nonhormonal methods, with the sharpest increase during the first six months after insertion.¹ The picture for hormonal IUDs is murkier and less alarming, but not entirely clean. What drives this connection involves the vaginal microbiome, menstrual changes, and the physical presence of a foreign object, and how those factors interact matters for what you can actually do about it.

The Copper IUD and BV Risk

The strongest evidence for an IUD-BV connection centers on the copper device. In a prospective cohort that tracked women before and after insertion, BV risk jumped about 50% in the first six months of copper IUD use compared to the six months before insertion, and it stayed elevated for at least 18 months.¹ A randomized trial that examined vaginal bacteria directly found that after six months of copper IUD use, Nugent scores (the standard lab measure for BV) were significantly higher than at enrollment, and significantly higher than in women randomized to an injectable hormonal method.²

A cross-sectional study comparing IUD users to nonusers found IUD users were nearly three times as likely to test positive for BV on a vaginal smear and were more likely to report abnormal discharge.³ And research comparing contraceptive methods head to head has found that oral contraceptives and condoms appear protective against BV, while IUD use is associated with a significant increase.⁴

One earlier longitudinal study initially reported higher raw BV rates in IUD users (37% versus about 19% in users of hormonal methods like the pill, ring, or patch), but after adjusting for factors like race and irregular bleeding, the difference was no longer statistically significant.⁵ That study was smaller, though, and the weight of subsequent and larger evidence points toward a genuine association, especially for copper devices.

Why the Copper IUD Shifts Your Vaginal Bacteria

A healthy vagina is dominated by Lactobacillus bacteria, which produce lactic acid and keep the environment acidic. BV happens when those protective bacteria lose ground and a mix of anaerobic organisms, particularly Gardnerella vaginalis, takes over. The copper IUD appears to tilt this balance through a few converging routes.

The most discussed mechanism involves menstrual changes. Copper IUDs commonly cause heavier and longer periods, and that extra menstrual blood matters microbiologically. Menstrual blood raises vaginal pH and delivers iron-rich proteins. Gardnerella and other BV-associated bacteria thrive on iron, and the longer that blood is present each cycle, the more opportunity these organisms have to grow.⁶ Even in women without an IUD, Lactobacillus populations dip during menstruation and then recover. With a copper IUD extending that window, the recovery may not fully happen before the next cycle begins.

Research looking at the vaginal microbiome in detail has confirmed this pattern. Copper IUD users show lower rates of Lactobacillus-dominated bacterial communities, higher rates of transition toward less optimal microbiome states, and increased vaginal inflammation.⁷ The randomized trial mentioned earlier found that copper IUD users had significantly greater bacterial diversity compared to hormonal contraceptive users, and in vaginal health, more diversity is usually bad news. A Lactobacillus-dominated community is low-diversity by design.²

What About Hormonal IUDs?

The levonorgestrel IUD (brands like Mirena, Kyleena, and Liletta) operates very differently from the copper version. It releases a progestin locally, which thins the uterine lining and typically makes periods lighter or stops them altogether. Since heavier bleeding is a major suspected driver of BV in copper IUD users, you might expect hormonal IUDs to be in the clear. The reality is less straightforward.

A large retrospective review of over 1,700 IUD insertions found nearly identical BV rates afterward: 2.4% for the levonorgestrel IUD and 2.3% for the copper IUD.⁸ A study specifically examining BV positivity among IUD users found no significant difference between hormonal and nonhormonal devices.⁹ And a study of women with adenomyosis found that those using a levonorgestrel IUD had about 22% higher BV risk compared to women taking oral norethindrone, suggesting that the device itself, not just its hormonal content, may play a role.¹⁰

The hormonal IUD does alter the cervicovaginal environment. Hormonal contraceptive users produce more viscous cervicovaginal fluid compared to women not using hormonal methods.¹¹ That thicker mucus could, in theory, be somewhat protective by acting as a barrier. But the physical presence of a device and its string in the cervix appears to create its own risk regardless of the hormonal environment. The bottom line is that if you are dealing with recurrent BV on a hormonal IUD, your device could still be a contributing factor, even though the evidence is weaker than for copper.

The Role of Biofilm on IUD Strings

Every IUD has a string (or tail) that hangs through the cervix into the upper vagina. That string is a surface, and bacteria readily colonize surfaces. Research examining the microbial composition on IUD strings at the time of removal has found some telling patterns. Devices removed because of symptoms (pain, discharge, bleeding) had higher overall bacterial loads and a greater share of non-Lactobacillus species, including potentially harmful genera like Fusobacterium, Haemophilus, and Gardnerella.¹²

Biofilms are communities of bacteria encased in a protective matrix that makes them difficult to treat with standard antibiotics. BV itself is increasingly understood as a biofilm-driven condition, with Gardnerella forming organized structures on vaginal tissue. An IUD string provides additional scaffolding for these biofilms to establish and persist. This is one reason BV can be stubborn to treat in IUD users and why it tends to come back, even after a course of antibiotics seems to clear it.

Why BV Is Harder to Treat When You Have an IUD

If you’ve experienced the frustrating cycle of treating BV only for it to return weeks later, your IUD may be part of the problem. An older but frequently cited study found that cure rates for BV treated with metronidazole were markedly lower in women using an IUD: roughly 57% compared to about 88% in nonusers.¹³ That is a substantial gap. Antibiotics can kill free-floating bacteria in the vaginal fluid, but they are far less effective at penetrating biofilms that have established themselves on the device and its string.

A clinical review focused on recurrent BV management recommends removing copper IUDs in women with BV that keeps coming back.¹⁴ The recommendation is strongest for copper devices, given the stronger evidence linking them to BV. Whether hormonal IUDs should also be removed in the same scenario is more debatable, and the same review notes the lack of data to make a firm call.

The encouraging part: the elevated risk appears to resolve after removal. In the prospective cohort that tracked copper IUD users over time, women who discontinued their device saw BV frequency return to pre-insertion rates within about a year.¹ The microbiome appears to recover once the physical and chemical disruptions caused by the device are gone.

Does Pre-Insertion Screening for BV Help?

You might wonder if getting tested for BV before your IUD goes in would prevent problems down the line. The evidence says it probably wouldn’t change much. A study that screened women at the time of insertion found five who tested BV-positive, and none of them developed complications afterward. There was no significant relationship between BV status at insertion and later outcomes.¹⁵

A study in Nigeria similarly found no significant association between BV status before insertion and complications afterward, with complication rates of about 31% in BV-positive women versus 23% in BV-negative women, a gap that was not statistically meaningful.¹⁶ A follow-up study of IUD users found that BV detected one month after insertion was not associated with device-related complications except for increased painful periods.¹⁷

This is worth knowing because some providers delay IUD placement if BV is present, and patients sometimes worry that having BV at the time of insertion will lead to pelvic inflammatory disease or other serious complications. The available evidence does not support routine BV screening as a prerequisite for IUD insertion. Current clinical guidelines from major reproductive health organizations reflect this, treating BV at the time of insertion as something to manage rather than as a reason to postpone the procedure.

Discharge Versus Actual BV

A common experience among IUD users is noticing more vaginal discharge after insertion and assuming they must have an infection. IUD users do report more abnormal discharge than nonusers, and research has confirmed that the complaint is about twice as common.³ But increased discharge can have multiple explanations. The cervix responds to a foreign body by producing more mucus. Hormonal IUDs alter the consistency of cervicovaginal fluid. And the string itself can wick cervical mucus down into the vagina where you notice it more.

Not all discharge is BV. The hallmark of BV is a thin, grayish-white discharge with a distinct fishy odor, especially after sex. If your discharge is clear or white and doesn’t smell particularly off, what you’re experiencing may be a normal response to the device rather than an infection. The only way to know for sure is testing, and if you’re getting recurrent symptoms, it’s worth getting a proper lab diagnosis rather than treating empirically, since treatment decisions differ depending on whether it’s actually BV, a yeast infection, or just increased physiological discharge.

Practical Decisions If You Have Recurrent BV with an IUD

The first question most people ask is whether they need to have their IUD removed. That depends on how severe and frequent the episodes are. If you’ve had one or two bouts that responded to treatment and haven’t come back, removal is probably unnecessary. If BV is recurring every few months despite treatment, the calculus changes, especially with a copper device. Clinical experts recommend considering copper IUD removal in that scenario and switching to a different contraceptive method.¹⁴

If you love your IUD and want to try to manage BV without removing it, standard antibiotic treatment is still the first-line approach. Vaginal metronidazole gel or oral metronidazole or clindamycin can clear an acute episode, though as noted, cure rates are lower with an IUD in place. Some providers use suppressive therapy, with periodic maintenance doses of vaginal antibiotics to prevent recurrence, though data on how well this works specifically in IUD users is thin.

Switching from a copper IUD to a hormonal one is sometimes suggested as a compromise: you keep the convenience of an IUD while potentially reducing the menstrual-blood-driven mechanism. Given that the hormonal IUD is not entirely off the hook for BV risk, this is a reasonable but not guaranteed fix. At least one study found similar BV rates between the two device types, so a switch may not solve the problem if the biofilm component is the main driver.

Experimental Approaches to IUD-Associated Infections

Researchers are working on ways to make IUDs themselves less hospitable to harmful bacteria. One approach involves coating IUD surfaces with antimicrobial substances. A lab study tested propolis (a resin-like material from beehives) as a coating for IUDs and found it reduced biofilm formation by roughly 44-46% for common test bacteria, with antibacterial inhibition efficiency reaching over 98%.¹⁸ These are bench-top results, not clinical trials, but they illustrate the direction of thinking.

Another line of research involves using protective Lactobacillus strains to outcompete harmful bacteria on the IUD surface. A study isolating Lactobacillus gasseri from the human vagina found that when co-incubated with IUD tails, the probiotic strain blocked 97% of Staphylococcus aureus adhesion and displaced about 99% of Candida already attached to the device surface.¹⁹ While promising, the jump from a lab dish to a working intravaginal product is enormous, and no probiotic-coated IUD is anywhere near market approval. Still, it signals that the field recognizes IUD-associated infection as a problem worth solving at the device level rather than only through repeated antibiotic courses.

For now, vaginal probiotic supplements containing Lactobacillus strains are widely marketed to women with recurrent BV. Evidence for their effectiveness in the general BV population is mixed, and no published trial has specifically tested whether vaginal probiotics reduce BV recurrence in IUD users. They are unlikely to cause harm, but expectations should be modest until better data arrive.

1
PubMed Central. Elevated Risk of Bacterial Vaginosis Among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort Study
2
Nature Communications. Copper intrauterine device increases vaginal concentrations of inflammatory anaerobes and depletes lactobacilli compared to hormonal options in a randomized trial
3
PubMed. Intrauterine device use and some issues related to sexually transmitted disease screening and occurrence
4
PubMed. Bacterial vaginosis and contraceptive methods
5
PubMed Central. Risk of Bacterial Vaginosis in Users of the Intrauterine Device: A Longitudinal Study
6
Frontiers in Microbiomes. The impact of contraceptives on the vaginal microbiome in the non-pregnant state – Section: 3.2 Nonhormonal intrauterine device (IUD)
7
PubMed Central. Effect of contraceptive methods on the vaginal microbiome and host immune factors
8
BMJ Sexual & Reproductive Health. P16 Bacterial vaginosis following copper and hormonal intrauterine device insertion
9
PubMed Central. Correlation of Bacterial Infections in Women With and Without Intrauterine Devices
10
PubMed Central. Risks of pelvic inflammatory disease and bacterial vaginosis in adenomyosis patients using levonorgestrel intrauterine device or oral norethindrone
11
PubMed Central. The effects of reproductive hormones on the physical properties of cervicovaginal fluid
12
PubMed Central. Microbial load and composition of intrauterine device string correlates with symptomatic removals in parous women
13
Gynecologic and Obstetric Investigation. Comparison of Oral and Vaginal Metronidazole Therapy for Nonspecific Bacterial Vaginosis
14
International Journal of Women’s Health. Understanding and Preventing Recurring Bacterial Vaginosis: Important Considerations for Clinicians
15
PubMed. Screening for bacterial vaginosis at the time of intrauterine contraceptive device insertion: is there a role?
16
Nigerian Postgraduate Medical Journal. Screening for Bacterial Vaginosis before Intrauterine Device Insertion at a Family Planning Clinic in South-West Nigeria
17
PubMed. Follow-up of users of intrauterine device with and without bacterial vaginosis and other cervicovaginal infections
18
Taylor & Francis Online (Journal of Biomaterials Science, Polymer Edition). Effects of propolis coating on antibacterial resistance of intrauterine devices
19
Sakarya University Journal of Science. Potential Use of Lactobacillus gasseri G10 Isolated from Human Vagina along with Intrauterine Devices (IUD) to Prevent Pathogen Colonization